Author(s):
Wasan K. Jawad, Ali M. Kadhim, Ahmed M. Issa, Rahman S. Zabibah
Email(s):
wisamhh92@gmail.com
DOI:
10.52711/0974-360X.2024.00643 
Address:
Wasan K. Jawad1, Ali M. Kadhim1, Ahmed M. Issa1*, Rahman S. Zabibah2
1Department of Biochemistry - Faculty of Medicine - Jabir ibn Hayyan University for Medical and Pharmaceutical Sciences – Najaf - Iraq.
2Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq.
*Corresponding Author
Published In:
Volume - 17,
Issue - 9,
Year - 2024
ABSTRACT:
Preeclampsia (PE) is a disorder of pregnancy characterized by the onset of high blood pressure and often a significant amount of protein in the urine. There is no individual marker satisfactory for the prediction of PE occurrence and many markers have been studied to discover the gold standard test that predicts the boundaries of PE severity. In this comparative case- control study, 118 pregnant women were recruited (44 healthy, 44 with mild PE and 30 with severe PE). The total serum bilirubin, glucose, BUN, total serum protein, albumin, alanine transaminase (ALT), aspartate transaminases (AST), gamma glutamyl transferase (GGT) and alkaline phosphatase (ALP) were measured. There were significant differences in all of the biochemical parameters in the severe PE groups when compared with the healthy control groups; a P value of < 0.001. However, significant associations were not observed for age, gravidity, and gestational age. Three parameters: GGT, total serum bilirubin, and albumin, achieved the highest percent of alteration in relation to healthy control levels; the values 320.66%, 50%, and – 26.21% respectively. These parameters are used to calculate the preeclampsia factor (PF), which was then engaged in detecting the boundary lines of PE groups and the interference areas or overlapping between peaks. The gathering of many biochemical parameters in one equation is a good approach to produce a factor that represents a reliable biochemical tool used successfully to outline the boundaries of PE groups and display the areas of overlap between them. This preeclampsia factor is a promising biochemical tool in patient monitoring, treatment, follow-up, and facilitating pregnant health care
Cite this article:
Wasan K. Jawad, Ali M. Kadhim, Ahmed M. Issa, Rahman S. Zabibah. New Preeclampsia Calculated Factor (PF) Detecting Severity in Healthy, Mild and Severe Cases. Research Journal of Pharmacy and Technology. 2024; 17(9):4154-0. doi: 10.52711/0974-360X.2024.00643
Cite(Electronic):
Wasan K. Jawad, Ali M. Kadhim, Ahmed M. Issa, Rahman S. Zabibah. New Preeclampsia Calculated Factor (PF) Detecting Severity in Healthy, Mild and Severe Cases. Research Journal of Pharmacy and Technology. 2024; 17(9):4154-0. doi: 10.52711/0974-360X.2024.00643 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-9-4
REFERENCES:
1. Cunningham F, Leveno K J, Bloom S L, et al. (Eds.). Williams Obstetrics 2018; 25th ed.New York: McGraw-Hill Education. https://accessmedicine.mhmedical.com /content. aspx?bookid=1918§ionid=185045008
2. Eiland E, Nzerue C, Faulkner M. Preeclampsia., J Pregnancy. 2012:586578. doi: 10.1155/2012/586578.
3. Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016; 387(10022): 999-1011. doi: 10.1016/S0140-6736(15)00070-7.
4. Magee LA, Sharma S, Nathan HL, Adetoro OO, Bellad MB, Goudar S, Macuacua SE, Mallapur A, Qureshi R, Sevene E, Sotunsa J, Valá A, Lee T, Payne BA, Vidler M, Shennan AH, Bhutta ZA, von Dadelszen P; CLIP Study Group. The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: A prospective population-level analysis. PLoS Med. 2019; 16(4): e1002783. doi: 10.1371/journal.pmed.1002783.
5. Majeed B A, Jasim S K, Al-Momen H, and Hussein M J. Iraqi Women with Preeclampsia: Maternal and Neonatal Outcomes.Open Access Macedonian J Med Sci. 2020; 8(B):866 - 870. https://doi.org/10.3889/oamjms.2020.5043
6. Wiles K, Damodaram M, Frise C. Severe hypertension in pregnancy. Clin Med (Lond). 2021; (5): e451-e456. doi: 10.7861/clinmed.2021-0508. .
7. Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, Kenny LC, McCarthy F, Myers J, Poon LC, Rana S, Saito S, Staff AC, Tsigas E, von Dadelszen P. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens. 2022; 27: 148-169. doi: 10.1016/j.preghy.2021.09.008.
8. Pittara T, Vyrides A, Lamnisos D. Giannakou K. Pre-eclampsia and long-term health outcomes for mother and infant: an umbrella review. BJOG. 2021; 128(9): 1421-1430. doi: 10.1111/1471-0528.16683.
9. Hoidy, W.H., Essa, S.M., Al-Saady, F.A., Jaffar Al-Mulla, E.A. Synthesis, characterization and evaluation of biological activity of corn oil-based difatty acyl carbamodithioic acid. Research Journal of Pharmacy and Technology. 2020; 13(4): 1931–1935. DOI: 10.5958/0974-360X.2020.00348.0
10. Mohsin, A.A., Radhi, M.M., Hoidy, W.H. Study the gold compound (AuCl4) in KCl using cyclic voltammetry by nano sensor. Research Journal of Pharmacy and Technology. 2021; 14(6): 3004–3008. DOI: 10.52711/0974-360X.2021.00526
11. Vaishali M. Antioxidants in Health and Diseases. Research Journal of Pharmacy and Technology. 2014;7(4);
12. Smith LG Jr, Moise KJ Jr, Dildy GA. Carpenter RJ Jr. Spontaneous rupture of liver during pregnancy: current therapy. Obstet Gynecol. 1991; 77(2): 171-5. doi: 10.1097/00006250-199102000-00001.
13. De Boer K, Büller HR, ten Cate JW, Treffers PE. Coagulation studies in the syndrome of haemolysis, elevated liver enzymes and low platelets. Br J Obstet Gynaecol.1991; 98(1): 42-7. doi: 10.1111/j.1471-0528.1991.tb10309.x.
14. Valenzuela GJ, Munson LA, Tarbaux NM, Farley JR. Time-dependent changes in bone, placental, intestinal, and hepatic alkaline phosphatase activities in serum during human pregnancy. Clin Chem. 1987; 33(10):1801-6.
15. Adeniyi F A, Olatunbosun D A. Origins and significance of the increased plasma alkaline phosphatase during normal pregnancy and preeclampsia. British Journal of Obstetrics and Gynaecology 1984; 91: 857-862. doi: 10.1111/j.1471-0528.1984.tb03697.x.
16. Steven MM. Pregnancy and liver disease. Gut. 1981; 22(7): 592-614. doi: 10.1136/gut.22.7.592.
17. Kumari M. J. Assess the Personal Factors of Reproductive Health among the Women. Asian Journal of Nursing Education and Research. 2016; 6(2): 221-224. DOI: 10.5958/2349-2996.2016.00041.0
18. Kritika Sh. Raman K, Manpreet, Shaveta Sh. A Descriptive Study to Assess the Health Profile and Warning Signs of Cancer among adults Residing in Selected Rural areas of District Roopnagar Punjab. Asian Journal of Nursing Education and Research. 2018; 8(3): 371-374 DOI: 10.5958/2349-2996.2018.00076.9
19. Nirmala J. A Case Report on Pica: A rare pregnancy related complication. Asian Journal of Nursing Education and Research. 2015; 5(1): 137-139. DOI: 10.5958/2349-2996.2015.00029.4
20. Khidri FF. Various Presentations of Preeclampsia at Tertiary Care Hospital of Sindh: A Cross-Sectional Study. Curr Hypertens Rev. 2020; 16(3): 216-222. doi: 10.2174/1573402115666191009120640.
21. Vousden N, Lawley E, Seed PT, Gidiri MF, Goudar S, Sandall J, Chappell LC, Shennan AH; CRADLE Trial Collaborative Group. Incidence of eclampsia and related complications across 10 low- and middle- resource geographical regions: Secondary analysis of a cluster randomised controlled trial. PLoS Med. 2019; 16(3): e1002775. doi: 10.1371/journal.pmed.1002775.
22. Paçarizi H, Begolli L, Lulaj S, Gafurri Z. Blood urea nitrogen/creatinine index is a predictor of prerenal damage in preeclampsia. Journal of Health Sciences. 2012; 2(1): 61-65. doi.org/10.17532/jhsci.2012.65
23. Swapan B. Interactions between Common Foods and Drugs -A Narrative Review. Asian Journal of Pharmaceutical Research. 2020; 10(3):188-194. DOI:10.5958/2231-5691.2020.00033.7
24. Devi S, Kumar P, Kumar P, Pooja, Gupta V. K. Survey on Impact of Lifestyle on Human Health in Urban and Rural Area. Asian Journal of Research in Pharmaceutical Science. 2022; 12(4): 281-284. DOI : 10.52711/2231-5659.2022.00048.
25. Mran AS, Manoj C, Avinash VK. Development of Spectrophotometric Method for Simultaneous Estimation of Flupenthixol HCl and Melitracen HCl in Their Combined Dosage Form, Asian Journal of Research in Chemistry. 2009; 2(4): 488- 493.
26. Roberts JM, Rich-Edwards JW, McElrath TF, Garmire L, Myatt L. Global Pregnancy Collaboration. Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness. Hypertension. 2021; 77(5): 1430-1441. doi: 10.1161/HYPERTENSIONAHA.120.14781.
27. Vigil-De Gracia P, Vargas C, Sánchez J, Collantes-Cubas J. Preeclampsia: Narrative review for clinical use. Heliyon. 2023; 9(3): e14187. doi: 10.1016/j.heliyon.2023.e14187.
28. Moharana JJ, Mishra R, Nayak AK. A Study on Serum Lactate Dehydrogenase and Uric Acid in Preeclampsia and Eclampsia: Can they Predict Adverse Fetomaternal Outcome? Int J Appl Basic Med Res. 2023; 13(2): 95-100. doi: 10.4103/ijabmr.ijabmr_626_22. Epub 2023 Jul 17.
29. Ekun OA, Olawumi OM, Makwe CC, Ogidi NO. Biochemical Assessment of Renal and Liver Function among Preeclamptics in Lagos Metropolis. Int J Reprod Med. 2018; 1594182. doi: 10.1155/2018/1594182.
30. Salma U. Relationship of serum lipid profiles in preeclampsia and normal pregnancy, Bangladesh. Afr Health Sci. 2022; 22(2): 475-479. doi: 10.4314/ahs.v22i2.55.
31. Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension. 2007; 50(1): 137- 42. doi: 10.1161/HYPERTENSIONAHA.107.087700
32. Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009; 30: 38-42. doi: 10.1016/j.placenta.2008.11.021.
33. Breslin E, Kaufmann A. Quenby S. Bilirubin influences the clinical presentation of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2013; 170(1):111-3. doi: 10.1016/j.ejogrb.2013.05.024.
34. Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011; 31(1): 33-46. doi: 10.1016/j.semnephrol.2010.10.004. PMID: 21266263.
35. Sibai BM, Ramadan MK, Usta I, Salama M. Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993; 169(4): 1000-6. doi: 10.1016/0002-9378(93)90043-i.
36. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005; 10; 308(5728): 1592-4. doi: 10.1126/science.1111726.
37. Wu J, Zhou W, Li Q, Yuan R, Li H, Cui S. Combined use of serum gamma glutamyl transferase level and ultrasonography improves prediction of perinatal outcomes associated with preeclamptic pregnancy. Clin Chim Acta. 2017; 475: 97-101. doi: 10.1016/j.cca.2017.09.018.
38. Chen Y, Ou W, Lin D, Lin M, Huang X, Ni S, Chen S, Yong J, O'Gara MC, Tan X, Liu R. Increased Uric Acid, Gamma-Glutamyl Transpeptidase and Alkaline Phosphatase in Early-Pregnancy Associated With the Development of Gestational Hypertension and Preeclampsia. Front Cardiovasc Med. 2021; 15(8): 756140. doi:10.3389/fcvm.2021.756140.
39. Elias SES, Eltom A, Osman AL, Babker AMA. Gamma glutamyl transferase and lactate dehydrogenase as biochemical markers of severity of preeclampsia among Sudanese pregnant women. Int J Reprod Contracept Obstet Gynecol. 2018; 7: 3020-3. https://www.ijrcog.org › index.php › ijrcog › article
40. Von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Côté AM, Douglas MJ, Gruslin A, Hutcheon JA, Joseph KS, Kyle PM, Lee T, Loughna P, Menzies JM, Merialdi M, Millman AL, Moore MP, Moutquin JM, Ouellet AB, Smith GN, Walker JJ, Walley KR, Walters BN, Widmer M, Lee SK, Russell JA, Magee LA; PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011; 15-377(9761): 219-27. doi: 10.1016/S0140-6736(10)61351-7.
41. Jijith US, Nair CR, Sudhakaran1, Pramod K. Acute toxicity and Gross Behavioural effects of Alcoholic Extract of Anamirta cocculus willd. Research Journal of Pharmacology and Pharmacodynamics. 2016; 8(1): 1-4. DOI: 10.5958/2321-5836.2016.00001.X
42. Jose BE, Muralidharan P. In Vitro Anti Cancer Activity of Leaf Extracts of Azima tetracantha Lam against Tryphan Blue Exclusion Method by using Dal Cell Lines. Research Journal of Pharmacology and Pharmacodynamics. 2019; 11(1): 23-26. DOI: 10.5958/2321-5836.2019.00005.3
43. Sharad D, Nilesh P. Demographic and Participation Details of Healthy Adult Human Participants of Early Phase Bioequivalence Pharmacokinetic Endpoint Study. Research Journal of Pharmacology and Pharmacodynamic. 2021; 13(4): DOI: 10.52711/2321-5836.2021.00033
44. Shiksha J, Ranjana A, Kamaljit B, Neeraj K. Preventive Measures and Suggested Guidelines to Reduce the Chemical Health Hazards on Medical Students and Educators. Research Journal of Pharmacology and Pharmacodynamics. 2015; 7(3): DOI: 10.5958/2321-5836.2015.00028.2